Recruiting Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure NCT07219459 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more Locations USC Norris Comprehensive Cancer Center — Los Angeles, California, United States Peidmont Healthcare, Inc — Atlanta, Georgia, United States OSF St. Francis Medical Center — Peoria, Illinois, United States Hannover Medical School — Hanover, Lower Saxony, Germany View all 14 locations View more locations Show fewer locations Loading locations... View Trial Details
